REGN
38
-2
CMA
61
-3
CPB
22
-5
A
37
-2
LEN
50
-2
FAST
57
-3
WMT
56
-4
SRE
63
2
NEE
54
7
O
17
-13
NI
72
4
CMS
60
2
AEP
54
6
ED
45
3
AAP
35
-9
FITB
60
-5
MSFT
48
-9
GIS
22
-4
GRMN
67
-4
SYF
86
-6
REGN
38
-2
CMA
61
-3
CPB
22
-5
A
37
-2
LEN
50
-2
FAST
57
-3
WMT
56
-4
SRE
63
2
NEE
54
7
O
17
-13
NI
72
4
CMS
60
2
AEP
54
6
ED
45
3
AAP
35
-9
FITB
60
-5
MSFT
48
-9
GIS
22
-4
GRMN
67
-4
SYF
86
-6
Financhill
Back

Dimensional Global Sstby FxdETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

DFSB
Dimensional Global Sstby FxdETF

Last Price:
52.05
Seasonality Move:
3.08%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
Dimensional Global Sstby FxdETF (DFSB) is a Sell

Is Dimensional Global Sstby FxdETF a Buy, Sell or Hold?

  • The current Dimensional Global Sstby FxdETF [DFSB] share price is $52.08. The Score for DFSB is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • DFSB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DFSB Stock Price Chart

What is Dimensional Global Sstby FxdETF's stock price today?

  • The Dimensional Global Sstby FxdETF share price today is $52.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DFSB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DFSB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 43.48 Sell
Chaikin Money Flow: 16772 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.99 - 52.53) Sell
Bollinger Bands (100): (51.68 - 52.94) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DFSB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.11 Sell
20-day SMA: 52.15 Sell
50-day SMA: 52.66 Sell
200-day SMA: 51.76 Buy
8-day EMA: 52.09 Sell
20-day EMA: 52.21 Sell
50-day EMA: 52.38 Sell
200-day EMA: 51.91 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Dimensional Global Sstby FxdETF Earnings Growth & DFSB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Dimensional Global Sstby FxdETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):